{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32848271",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0026-6620",
      "JournalIssue": {
        "Volume": "117",
        "Issue": "4",
        "PubDate": {
          "Year": "2020",
          "Season": "Jul-Aug"
        }
      },
      "Title": "Missouri medicine",
      "ISOAbbreviation": "Mo Med"
    },
    "ArticleTitle": "<i>Staphylococcus aureus</i> Bacteremia: Contemporary Management.",
    "Pagination": {
      "StartPage": "341",
      "EndPage": "345",
      "MedlinePgn": "341-345"
    },
    "Abstract": {
      "AbstractText": [
        "<i>Staphylococcus aureus</i> bacteremia (SAB) is a serious cause of bloodstream infection associated with significant morbidity and mortality. Complications include deep-seated foci of infection including infective endocarditis, device-associated infection, osteoarticular metastases, pleuropulmonary involvement, and recurrent infection. With the 30-day all-cause mortality being around 20%, a collaborative effort of early Infectious Diseases (ID) consultation and Antimicrobial Stewardship Program (ASP) involvement will show improved SAB outcomes and therapy optimization.1."
      ],
      "CopyrightInformation": "Copyright 2020 by the Missouri State Medical Association."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Diseases Fellow, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri."
          }
        ],
        "LastName": "Abraham",
        "ForeName": "Leny",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chief, Infectious Diseases, Truman Medical Center, Medical Director, Sexual Health Clinic, Kansas City Health Department, and Professor of Medicine, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri."
          }
        ],
        "LastName": "Bamberger",
        "ForeName": "David M",
        "Initials": "DM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Mo Med",
    "NlmUniqueID": "0400744",
    "ISSNLinking": "0026-6620"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "methods",
        "standards",
        "statistics & numerical data"
      ],
      "DescriptorName": "Antimicrobial Stewardship"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "physiopathology"
      ],
      "DescriptorName": "Bacteremia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "physiopathology"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Staphylococcus aureus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}